Blar i Institutt for klinisk og molekylær medisin på forfatter "Tafjord, Gunnar"
-
Downstaging and survival after Neoadjuvant chemotherapy for bladder cancer in Norway; a population-based study
Møller, Christina Tanem; Støer, Nathalie Charlotte; Blindheim, Augun; Berge, Viktor; Tafjord, Gunnar; Fosså, Sophie Dorothea; Kulle, Bettina (Peer reviewed; Journal article, 2022)Background Neoadjuvant chemotherapy (NAC) before radical cystectomy is associated with pathological downstaging (DS) and improved overall survival (OS) in patients with muscle-invasive bladder cancer (MIBC). Population-based ... -
Initial management and survival of patients with primary metastatic bladder cancer before the immunotherapy era: a population-based study from Norway
Møller, Christina Tanem; Tafjord, Gunnar; Blindheim, Augun Jodis; Berge, Viktor; Fosså, Sophie Dorothea; Kulle, Bettina (Peer reviewed; Journal article, 2023)Before immunotherapy became part of the management of metastatic bladder cancer (mBC), systemic anti-cancer treatment comprised primarily of platinum-based chemotherapy. The objective of this study was to describe the ...